Navigation Links
nContact's Corporate Website Recognized as Best in Class Medical Site by Interactive Media Council - www.ncontactinc.com
Date:1/11/2012

MORRISVILLE, N.C., Jan. 11, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced that its recently launched corporate website, www.ncontactinc.com, has won a 2011 Interactive Media Award for Best in Class Medical Site, presented by the nonprofit Interactive Media Council. The new website, designed by Studio 1440, has been recognized for excellence in design, development and implementation, through a competition of over 500 international and domestic websites.

John P. Funkhouser, President and CEO of nContact, said, "We designed our new website to represent the direction and vision of our company as we pioneer new treatment alternatives for common cardiac arrhythmias.  As we continue to advance our technology and expand treatments to new patient populations, we will look to our website to chronicle our evolution. We appreciate that our efforts have been acknowledged through this prestigious interactive forum and that the concept, design and content has earned such recognition."

nContact's newly enhanced corporate website, with portals for both U.S. and International visitors, provides an in-depth view of the company's Numeris® and EPi-Sense® Guided Coagulation Systems with VisiTrax®, expanded physician resources, detailed images and animation videos.

The "Best in Class" award recognizes the website meets and surpasses standards of excellence in design, usability, innovation in technical features, standards compliance and content, receiving a near perfect score in each category. It is the most prestigious award presented by the Interactive Media Council each year.

About nContact, Inc.nContact is a medical device company founded in 2005 with a mission to develop devices for the endoscopic treatment of arrhythmias, including atrial fibrillation (AF). The Numeris® Coagulation System with VisiTrax® is based
'/>"/>

SOURCE nContact, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Incorporated Announces Third Quarter 2007 Financial Results
3. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
4. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
6. AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
7. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
8. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
9. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
10. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
11. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... EDGE, N.J. , May 23, 2013 ... a commercial stage medical device company that develops and ... successful completion of its rights offering.  In addition, the ... March 2011 warrants expired on May 17, 2013. ... of $3.0 million from the rights offering.   A portion ...
(Date:5/23/2013)... 2013  TeamHealth Medical Call Center (THMCC), a ... advice lines, announces its newly formed Clinical Advisory ... administrative leaders, provides clinical expertise to advance THMCC,s ... for hospital clients, physician clients and patients. ... it,s imperative to continuously advance our services and ...
(Date:5/23/2013)... MONICA, Calif. , May 23, 2013 ... a program that would have required them to obtain ... today by Consumer Watchdog and Whatley Kallas LLC.  ... Diego Superior Court, alleged that Blue Cross,s mandatory mail ... patients, threatening their health and privacy. "This ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... -- Metabasis,Therapeutics, Inc. announced today that a poster ... Tolerability and Pharmacokinetics,(PK) of Intravenous (IV) Infusion of ... be presented at,the 2007 annual meeting of the ... CA. The presentation will take,place on April 16, ...
... A study comparing,the formulations of isosorbide dinitrate (ISDN) ... II, and BiDil, the proprietary,fixed dose combination, used ... no bioequivalence. Non-bioequivalence,in the formulations used may explain ... results in decreasing mortality. Using,identical amounts of active ...
Cached Medicine Technology:Metabasis Therapeutics to Present Poster at American Association,for Cancer Research 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5
(Date:5/24/2013)... respected Alzheimer,s researchers failed to replicate what appeared to ... disease when they were published last year in the ... Feb. 9, 2012, suggested that the drug bexarotene (marketed ... amyloid plaques (Aβ) a pathological hallmark of Alzheimer,s ... the authors of the 2012 report, drug treatment quickly ...
(Date:5/24/2013)... Salt Lake City, Utah (PRWEB) May 24, 2013 ... AnatomyOne 2.0 , with exciting new enhancements for instructors ... help students stay more focused through personalize learning plan ... the new AnatomyOne release provides 500 new assessment questions, ... make and review notes. , AnatomyOne 2.0 ...
(Date:5/24/2013)... 24, 2013 Mr. Brian Su, CEO ... Annual EB-5 Investment Summit: Dealmakers Conference in Long Beach, ... focus on exploring alternative finance through EB-5 immigrant investors ... and economic information, and updates to project developers, regional ... industry. , "Our goal is to assist EB-5 ...
(Date:5/24/2013)... York, NY (PRWEB) May 24, 2013 ... Yahoo Commerce VP, Brandon Huff as Executive Vice President ... its commerce business units, which represented a large portion ... lead digital growth as Dwell develops a fully-integrated commerce ... a decade of experience monetizing digital content for leading ...
(Date:5/24/2013)... Stoler believes that there is much to be learned ... That’s why he hosts “Building New York—New York ... that’s why he invited Robert Glazer, Chief Executive Officer ... specialty practice in the greater New York area, whose ... sub-specialists service communities throughout New York and New Jersey ...
Breaking Medicine News(10 mins):Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4
... funding source to public health , ... Prevention today unveiled health reform recommendations to Congress that ... tackle the chronic diseases that are causing medical costs ... Under these proposals, federally funded insurance programs would provide ...
... Karmanos, Work It Out (DKWIO), a,dynamic 501(c)(3) not-for-profit program ... today announced that Tracey Secco has joined,DKWIO as Director ... ten years,of experience in public relations and program management ... organization,s life-changing message. , ...
... Dec. 11 PURE Bioscience,(Nasdaq: PURE ), ... reported revenues for the fiscal quarter ended October,31, 2008 ... same quarter,last year. The Company reported a loss ... for the current quarter compared with a,loss of $(1,008,700), ...
... beta agonists may cause asthma problems and death, agency ... safety of four asthma medications will be weighed by a ... of hearings end Thursday. , The controversy over these drugs ... officials recently calling for banning the use of these drugs ...
... in Pennsylvania to open store in Mechanicsburg,s , ... CAMP HILL, Pa., Dec. 11 As individuals and seniors ... and small business owners look for health plan options, Highmark ... health insurer in the state to open a health insurance ...
... and founder of Allergy & Asthma Network Mothers of ... access to all forms of 12-hour bronchodilators at a ... Safety and Risk Management Advisory Committee and Pediatric Advisory ... Rockville, MD. , , ...
Cached Medicine News:Health News:Partnership for Prevention Offers Health Reform Recommendations to Congress 2Health News:Partnership for Prevention Offers Health Reform Recommendations to Congress 3Health News:Danialle Karmanos' Work It Out Names Tracey Secco as Director of Operations 2Health News:PURE Bioscience Reports First Quarter Results 2Health News:PURE Bioscience Reports First Quarter Results 3Health News:PURE Bioscience Reports First Quarter Results 4Health News:PURE Bioscience Reports First Quarter Results 5Health News:PURE Bioscience Reports First Quarter Results 6Health News:FDA Panel Mulls Safety of Asthma Meds 2Health News:FDA Panel Mulls Safety of Asthma Meds 3Health News:Highmark Blue Shield to Open 'Highmark Direct,' a Health Insurance Retail Store 2Health News:Highmark Blue Shield to Open 'Highmark Direct,' a Health Insurance Retail Store 3Health News:AANMA Provides Commentary to FDA Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators 2
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
... German Craftsmanship have produced ... in the world. Ocutek® ... to you! Only holders ... certificate, which requires and ...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
Medicine Products: